Don't forget! IHOP gives away free pancakes today

IHOP gives away free pancakes as part of its annual fundraiser for the Leukemia & Lymphoma Society. Customers who take advantage of the free food are encouraged to make a donation to the charity. The giveaway takes place from 7 a.m. to 10 p.m. today.
To celebrate National Pancake Day, each year International House of Pancakes (IHOP) offers a FREE short stack of pancakes to all guests visiting participating restaurants. Each year, LLS volunteers and IHOP staff come together to collect donations for The Leukemia & Lymphoma Society's mission in lieu of payment for pancakes.
This year, IHOP is hoping to stack up more donations than ever before, with a goal to raise $1.75 million, for a total of $5 million in five years with its National Pancake Day fundraising effort.
You can get involved by dining at your local IHOP or by volunteering to collect donations in one of the participating IHOPs on National Pancake Day each year. For more information or to find out how to volunteer please contact Rachel Holt at the Society: (703) 960-1100, ext. 228 or email rachel.holt@lls.org.
To learn more about National Pancake Day, call 703-399-2900 or
To learn more about National Pancake Day, visit http://www.leukemia-lymphoma.org/all_cal_detail.adp?item_id=597499

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap